Marco Londei
Nessuna posizione attualmente
Profilo
Marco Londei worked as the Head-Therapeutic Area Immunosciences at Bristol Myers Squibb Co. from 2012 to 2014.
Prior to that, he was the Global Head-Autoimmunity Translational Medicine at Novartis Corp.
from 2005 to 2008.
From 2014 to 2020, he served as the Chief Medical Officer at AnaptysBio, Inc. He was also a Professor at Imperial College London from 1999 to 2013 and a Professor & Head-Gastroenterology Unit at University College London from 2003 to 2007.
Additionally, he worked as a Translational Science Officer at Novartis Institute for Functional Genomics, Inc. from 2005 to 2012.
Dr. Londei earned a doctorate degree from Alma Mater Studiorum - Università di Bologna.
Precedenti posizioni note di Marco Londei
| Società | Posizione | Fine |
|---|---|---|
| ANAPTYSBIO, INC. | Direttore Tecnico/Scientifico/R&S | 25/03/2020 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/09/2014 |
| Imperial College London | Corporate Officer/Principal | 01/07/2013 |
Novartis Institute for Functional Genomics, Inc.
 Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/10/2012 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/08/2008 |
Formazione di Marco Londei
| Alma Mater Studiorum - Università di Bologna | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ANAPTYSBIO, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Aziende private | 2 |
|---|---|
Novartis Institute for Functional Genomics, Inc.
Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA. | Commercial Services |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
- Borsa valori
- Insiders
- Marco Londei
